Exercise therapy for sexual dysfunction after prostate cancer

Nature Reviews Urology

Volumn 10, Issue 12, 2013, Pages 731-736

  Cormie, Prue ^a   Newton, Robert U ^a   Taaffe, Dennis R ^a   Spry, Nigel ^a   Galvão, Daniel A ^a  

^a EDITH COWAN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ADVERSE OUTCOME; ANXIETY; BEHAVIOR CHANGE; BODY COMPOSITION; CANCER SURVIVOR; CANCER THERAPY; CLINICAL EFFECTIVENESS; COMORBIDITY; DEPRESSION; FATIGUE; FEMINIZATION; HEALTH CARE NEED; HUMAN; KINESIOTHERAPY; MALE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL HEALTH;

ERECTILE DYSFUNCTION; EXERCISE THERAPY; HUMANS; MALE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SEXUAL BEHAVIOR;

EID: 84890437393     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2013.206     Document Type: Review

References (71)

1. Australian Institute of Health and Welfare & Australasian Association of Cancer Registries. Cancer in Australia: an overview 2012 [online], http://www.aihw.gov.au/publication-detail/?id=60129542359 (2012).
2. Sanda, M. G. et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl. J. Med. 358, 1250-1261 (2008).
3. Bober, S. L. & Varela, V. S. Sexuality in Adult Cancer Survivors: Challenges and Intervention. J. Clin. Oncol. 30, 3712-3719 (2012).
4. Sadovsky, R. et al. Cancer and sexual problems. J. Sex. Med. 7, 349-373 (2010).
5. Resnick, M. J. et al. Long-term functional outcomes after treatment for localized prostate cancer. N. Engl. J. Med. 368, 436-445 (2013).
6. Stanford, J. L. et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 283, 354-360 (2000).
7. Spry, N. A. et al. Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. Eur. J. Cancer 42, 1083-1092 (2006).
8. Hamilton, A. S. et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J. Clin. Oncol. 19, 2517-2526 (2001).
9. Parker, W. R., Wang, R., He, C. & Wood, D. P. Jr. Five year expanded prostate cancer index composite-based quality of life outcomes after prostatectomy for localized prostate cancer. BJU Int. 107, 585-590 (2011).
10. Higano, C. S. Sexuality and Intimacy After Definitive Treatment and Subsequent Androgen Deprivation Therapy for Prostate Cancer. J. Clin. Oncol. 30, 3720-3725 (2012).
11. Ng, E. et al. The Influence of Testosterone Suppression and Recovery on Sexual Function in Men With Prostate Cancer: Observations From a Prospective Study in Men Undergoing Intermittent Androgen Suppression. J. Urol. 187, 2162-2167 (2012).
12. Elliott, S., Latini, D. M., Walker, L. M., Wassersug, R. & Robinson, J. W. Androgen Deprivation Therapy for Prostate Cancer: Recommendations to Improve Patient and Partner Quality of Life. J. Sex. Med. 7, 2996-3010 (2010).
13. Reese, J. B. Coping with sexual concerns after cancer. Curr. Opin. Oncol. 23, 313-321 (2011).
14. Penson, D. F. et al. Is Quality of Life Different for Men with Erectile Dysfunction and Prostate Cancer Compared to Men with Erectile Dysfunction Due to Other Causes? Results from the ExCEED Data Base. J. Urol. 169, 1458-1461 (2003).
15. Singer, P. A. et al. Sex or survival: trade-offs between quality and quantity of life. J. Clin. Oncol. 9, 328-334 (1991).
16. Smith, D. P. et al. Age, Health, and Education Determine Supportive Care Needs of Men Younger Than 70 Years With Prostate Cancer. J. Clin. Oncol. 25, 2560-2566 (2007).
17. Miles, C. L. et al. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database Syst. Rev. Issue 4. Art. No.: CD005540 http://dx.doi.10.1002/14651858.CD005540.pub2 (2007).
18. Magheli, A. & Burnett, A. L. Erectile dysfunction following prostatectomy: prevention and treatment. Nat. Rev. Urol. 6, 415-427 (2009).
19. Ottenbacher, A. et al. Cancer-Specific Concerns and Physical Activity Among Recently Diagnosed Breast and Prostate Cancer Survivors. Integr. Cancer Ther. 12, 206-212 (2013).
20. Bacon, C. G. et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann. Intern. Med. 139, 161-168 (2003).
21. Weber, M. F. et al. Risk factors for erectile dysfunction in a cohort of 108,477 Australian men. Med. J. Aust. 199, 107-111 (2013).
22. Poston, D. L. & Baumle, A. K. Patterns of asexuality in the United States. Demographic Res. 23, 509-530 (2010).
23. Seftel, A. D. Erectile Dysfunction in the Elderly: Epidemiology, Etiology and Approaches to Treatment. J. Urol. 169, 1999-2007 (2003).
24. Derby, C. A. et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 56, 302-306 (2000).
25. Bacon, C. G. et al. A Prospective Study of Risk Factors for Erectile Dysfunction. J. Urol. 176, 217-221 (2006).
26. Sharifi, N., Gulley, J. L. & Dahut, W. L. Androgen deprivation therapy for prostate cancer. JAMA 294, 238-244 (2005).
27. Collier, A., Ghosh, S., McGlynn, B. & Hollins, G. Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease: a review. Am. J. Clin. Oncol. 35, 504-509 (2012).
28. Galvao, D. A., Taaffe, D. R., Spry, N. & Newton, R. U. Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis. 10, 340-346 (2007).
29. Levine, G. N. et al. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. Circulation 121, 833-840 (2010).
30. Zaider, T., Manne, S., Nelson, C., Mulhall, J. & Kissane, D. Loss of Masculine Identity, Marital Affection, and Sexual Bother in Men with Localized Prostate Cancer. J. Sex. Med. 9, 2724-2732 (2012).
31. Klaeson, K., Sandell, K. & Bertero, C. M. Sexuality in the context of prostate cancer narratives. Qual. Health Res. 22, 1184-1194 (2012).
32. Hoyt, M. A., Stanton, A. L., Irwin, M. R. & Thomas, K. S. Cancer-related masculine threat, emotional approach coping, and physical functioning following treatment for prostate cancer. Health Psychol. 32, 66-74 (2013).
33. Peltier, A., van Velthoven, R. & Roumeguère, T. Current management of erectile dysfunction after cancer treatment. Curr. Opin. Oncol. 21, 303-309 (2009).
34. Burnett, A. L. Erectile Dysfunction. J. Urol. 175, S25-S31 (2006).
35. Wespes, E. et al. EAU Guidelines on Erectile Dysfunction: An Update. Eur. Urol. 49, 806-815 (2006).
36. Schover, L. R. et al. The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer 95, 2397-2407 (2002).
37. Stephenson, R. A. et al. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study. J. Urol. 174, 646-650 (2005).
38. Tal, R., Jacks, L. M., Elkin, E. & Mulhall, J. P. Penile implant utilization following treatment for prostate cancer: analysis of the SEER-Medicare database. J. Sex. Med. 8, 1797-1804 (2011).
39. Nelson, C. J., Deveci, S., Stasi, J., Scardino, P. T. & Mulhall, J. P. Sexual bother following radical prostatectomy. J. Sex. Med. 7, 129-135 (2010).
40. Brotto, L. A., Yule, M. & Breckon, E. Psychological interventions for the sexual sequelae of cancer: a review of the literature. J. Cancer Surviv. 4, 346-360 (2010).
41. Melnik, T., Soares, B. G. & Nasselo, A. G. Psychosocial interventions for erectile dysfunction. Cochrane Database of Systematic Reviews, Issue 9. Art. No.: CD004825. http://dx.doi.org/10.1002/14651858.CD004825.pub2 (2007).
42. Faller, H. et al. Effects of Psycho-Oncologic Interventions on Emotional Distress and Quality of Life in Adult Patients With Cancer: Systematic Review and Meta-Analysis. J. Clin. Oncol. 31, 782-793 (2013).
43. Chambers, S. K., Pinnock, C., Lepore, S. J., Hughes, S. & O'Connell, D. L. A systematic review of psychosocial interventions for men with prostate cancer and their partners. Patient Educ. Couns. 85, e75-e88 (2011).
44. La Vignera, S., Condorelli, R., Vicari, E., D'Agata, R. & Calogero, A. E. Physical activity and erectile dysfunction in middle-aged men. J. Androl. 33, 154-161 (2012).
45. Segal, R. J. et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J. Clin. Oncol. 27, 344-351 (2009).
46. Schmitz, K. H. et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med. Sci. Sports Exerc. 42, 1409-1426 (2010).
47. Galvao, D. A., Taaffe, D. R., Spry, N., Joseph, D. & Newton, R. U. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J. Clin. Oncol. 28, 340-347 (2010).
48. Galvao, D. A., Taaffe, D. R., Spry, N. & Newton, R. U. Physical activity and genitourinary cancer survivorship. Recent Results Cancer Res. 186, 217-236 (2011).
49. Maas, R., Schwedhelm, E., Albsmeier, J. & Boger, R. H. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc. Med. 7, 213-225 (2002).
50. Nicolosi, A., Moreira, E. D. Jr, Shirai, M., Bin Mohd Tambi, M. I. & Glasser, D. B. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 61, 201-226 (2003).
51. Pinnock, C. B., Stapleton, A. M. & Marshall, V. R. Erectile dysfunction in the community: a prevalence study. Med. J. Aust. 171, 353-357 (1999).
52. Hsiao, W. et al. Exercise is associated with better erectile function in men under 40 as evaluated by the International Index of Erectile Function. J. Sex. Med. 9, 524-530 (2012).
53. White, J. R., Case, D. A., McWhirter, D. & Mattison, A. M. Enhanced sexual behavior in exercising men. Arch. Sex. Behav. 19, 193-209 (1990).
54. Dahn, J. R. et al. Physical activity and sexual functioning after radiotherapy for prostate cancer: beneficial effects for patients undergoing external beam radiotherapy. Urology 65, 953-958 (2005).
55. Maio, G., Saraeb, S. & Marchiori, A. Physical activity and PDE5 inhibitors in the treatment of erectile dysfunction: results of a randomized controlled study. J. Sex. Med. 7, 2201-2208 (2010).
56. Lamina, S., Okoye, C. G. & Dagogo, T. T. Therapeutic effect of an interval exercise training program in the management of erectile dysfunction in hypertensive patients. J. Clin. Hypertens. (Greenwich) 11, 125-129 (2009).
57. Khoo, J. et al. Comparing Effects of Low- and High-Volume Moderate-Intensity Exercise on Sexual Function and Testosterone in Obese Men. J. Sex. Med. 10, 1823-1832 (2013).
58. Esposito, K. et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291, 2978-2984 (2004).
59. Esposito, K. et al. Effects of Intensive Lifestyle Changes on Erectile Dysfunction in Men. J. Sex. Med. 6, 243-250 (2009).
60. Cormie, P. et al. Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial. Prostate Cancer Prostatic Dis. 16, 170-175 (2013).
61. Newton, R. U. et al. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer. BMC Cancer 9, 210 (2009).
62. Chambers, S. K. et al. Pros Can for Couples: Randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy. BMC Cancer 8, 226 (2008).
63. Chambers, S. K. et al. Couple Distress after Localised Prostate Cancer. Support Care Cancer http://dx.doi:10.1007/s00520-013-1868-6.
64. Rock, C. L. et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J. Clin. 62, 242-274 (2012).
65. Smith, W. A., Nolan, V. G., Robison, L. L., Hudson, M. M. & Ness, K. K. Physical activity among cancer survivors and those with no history of cancer-a report from the National Health and Nutrition Examination Survey 2003 2006. Am. J. Transl. Res. 3, 342-350 (2011).
66. Blanchard, C. M., Courneya, K. S. & Stein, K. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J. Clin. Oncol. 26, 2198-2204 (2008).
67. Kwon, S., Hou, N. & Wang, M. Comparison of physical activity levels between cancer survivors and non-cancer participants in the 2009 BRFSS. J. Cancer Surviv. 6, 54-62 (2012).
68. Humphries, B., Duncan, M. J. & Mummery, W. K. Prevalence and correlates of resistance training in a regional Australian population. Br. J. Sports Med. 44, 653-656 (2010).
69. Centers for Disease Control and Prevention (CDC). Trends in strength training-United States, 1998-2004. MMWR Morb. Mortal. Wkly Rep. 55, 769-772 (2006).
70. Pinto, B. M. & Ciccolo, J. T. in Physical Activity and Cancer (eds Courneya, K. S. & Friedenreich, C. M.) 367-87 (Springer, London, 2011).
71. Blaney, J. M., Lowe-Strong, A., Rankin-Watt, J., Campbell, A. & Gracey, J. H. Cancer survivors' exercise barriers, facilitators and preferences in the context of fatigue, quality of life and physical activity participation: a questionnaire-survey. Psychooncology 22, 186-194 (2013).